Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Anticancer Research|November 2, 2010
High prevalence of human anti-mouse antibodies in the serum of colorectal cancer patientsMaki Goto, Kageaki Kuribayashi, Yoshifumi Umemori, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 17, 2009
Prevalence of human anti-mouse antibodies (HAMAs) in routine examinationsSaori Koshida, Koichi Asanuma, Kageaki Kuribayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 18, 2022
Study of post-opening stability of active ingredients in hand sanitizersRyo Kobayashi, Ryosei Murai, Yuki Sato, et al.
Anticancer Research|August 10, 2002
Decreased gene expression for telomeric-repeat binding factors and TIN2 in malignant hematopoietic cellsKoji Yamada, Atsuhito Yagihashi, Mikako Yamada, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2005
Detection of autoantibodies to survivin and livin in sera from patients with breast cancerAtsuhito Yagihashi, Tohsei Ohmura, Koichi Asanuma, et al.
Anticancer Research|August 10, 2002
Survivin mRNA expression in patients with breast cancerShunichi Nasu, Atsuhito Yagihashi, Akiko Izawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 28, 2021
Determination of reactivation rate and risk factors for Hepatitis B virus reactivation in low-positive cases: A retrospective cohort studyHitoshi Yonezawa, Shingo Tanaka, Momoko Furuya, et al.
Cancer Science|January 15, 2004
Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patientsMasashi Nakamura, Naoki Tsuji, Koichi Asanuma, et al.
Anticancer Research|January 18, 2003
Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancerAkiko Izawa, Daisuke Kobayashi, Shunichi Nasu, et al.
Pageof 3